Reviva Pharmaceuticals (RVPH) Insider Trading & Ownership → He cracked the code to crypto… (From Weiss Ratings) (Ad) Free RVPH Stock Alerts $1.71 -0.12 (-6.56%) (As of 05/15/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Reviva Pharmaceuticals (NASDAQ:RVPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.83%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$157,570.00Number OfInsiders Selling(Last 3 Years)0 Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RVPH Insider Buying and Selling by Quarter Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Reviva Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2022Purav PatelDirectorBuy3,000$4.69$14,070.00 9/30/2022Prabhu NarayanCFOBuy50,000$1.66$83,000.00 6/30/2022Prabhu NarayanCFOBuy50,000$1.21$60,500.00 (Data available from 1/1/2013 forward) RVPH Insider Trading Activity - Frequently Asked Questions Who is on Reviva Pharmaceuticals's Insider Roster? The list of insiders at Reviva Pharmaceuticals includes Prabhu Narayan, and Purav Patel. Learn more on insiders at RVPH. What percentage of Reviva Pharmaceuticals stock is owned by insiders? 31.83% of Reviva Pharmaceuticals stock is owned by insiders. Learn more on RVPH's insider holdings. Which Reviva Pharmaceuticals insiders have been buying company stock? The following insiders have purchased RVPH shares in the last 24 months: Prabhu Narayan ($143,500.00), and Purav Patel ($14,070.00). How much insider buying is happening at Reviva Pharmaceuticals? Insiders have purchased a total of 103,000 RVPH shares in the last 24 months for a total of $157,570.00 bought. More Insider Trading Tools from MarketBeat Related Companies: Anebulo Pharmaceuticals Insider Transactions Tempest Therapeutics Insider Transactions LifeVantage Insider Transactions vTv Therapeutics Insider Transactions Hookipa Pharma Insider Transactions Jaguar Health Insider Transactions Corvus Pharmaceuticals Insider Transactions Rallybio Insider Transactions Marinus Pharmaceuticals Insider Transactions SCYNEXIS Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:RVPH) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.